Perceived diagnostic delay and cancer-related distress: a cross-sectional study of patients with colorectal cancer

Psycho-Oncology

Volumn 26, Issue 1, 2017, Pages 29-36

  Miles, Anne ^a   McClements, Paula L ^b   Steele, Robert J C ^c   Redeker, Claudia ^a   Sevdalis, Nick ^d   Wardle, Jane ^e  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b INFORMATION SERVICES DIVISION   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVOR; COLORECTAL CANCER; CROSS-SECTIONAL STUDY; DELAYED DIAGNOSIS; DISTRESS SYNDROME; FEAR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; COLORECTAL TUMOR; HEALTH BEHAVIOR; HEALTH STATUS; MENTAL STRESS; MIDDLE AGED; PERCEPTION; PSYCHOLOGY; SCOTLAND; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; DELAYED DIAGNOSIS; FEAR; FEMALE; HEALTH BEHAVIOR; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERCEPTION; QUALITY OF LIFE; SCOTLAND; STRESS, PSYCHOLOGICAL;

EID: 84958259563     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.4093     Document Type: Article

References (42)

1. Thomson CS, Forman D. Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? Brit J Cancer 2009;101:S102–S109. DOI:10.1038/sj.bjc.6605399.
2. Austoker J, Bankhead C, Forbes LJ, et al. Interventions to promote cancer awareness and early presentation: systematic review. Brit J Cancer 2009;101:S31–S39. DOI:10.1038/sj.bjc.6605388.
3. Mansell G, Shapley M, Jordan JL, et al. Interventions to reduce primary care delay in cancer referral: a systematic review. Brit J Gen Pract 2011;61:e821–e835. DOI:10.3399/bjgp11X613160.
4. Miles A, Wardle J, Atkin W. Receiving a screen-detected diagnosis of cancer: the experience of participants in the UK flexible sigmoidoscopy trial. Psycho-Oncology 2003;12:784–802.
5. Green BL, Rowland JH, Krupnick JL, et al. Prevalence of posttraumatic stress disorder in women with breast cancer. Psychosomatics 1998;39:102–111.
6. Brocken P, van der Heijden EH, Oud KT, et al. Distress in suspected lung cancer patients following rapid and standard diagnostic programs: a prospective observational study. Psycho-Oncology 2015;24:433–441. DOI:10.1002/pon.3660.
7. Holland J, Watson M, Dunn J. The IPOS new International Standard of Quality Cancer Care: integrating the psychosocial domain into routine care. Psycho-Oncology 2011;20:677–680. DOI:10.1002/pon.1978.
8. Kangas M, Henry JL, Bryant RA. The course of psychological disorders in the 1st year after cancer diagnosis. J Consult Clin Psychol 2005;73:763–768.
9. Okamura M, Yamawaki S, Akechi T, et al. Psychiatric disorders following first breast cancer recurrence: prevalence, associated factors and relationship to quality of life. Jpn J Clin Oncol 2005;35:302–309.
10. Abbey G, Thompson SB, Hickish T, et al. A meta-analysis of prevalence rates and moderating factors for cancer-related post-traumatic stress disorder. Psycho-Oncology 2015;24:371–381. DOI:10.1002/pon.3654.
11. Smith MY, Redd WH, Peyser C, et al. Post-traumatic stress disorder in cancer: a review. Psycho-Oncology 1999;8:521–537.
12. Kangas M. DSM-5 trauma and stress-related disorders: implications for screening for cancer-related stress. Front Psychiatry 2013;4:122. DOI:10.3389/fpsyt.2013.00122.
13. Norton TR, Manne SL, Rubin S, et al. Prevalence and predictors of psychological distress among women with ovarian cancer. J Clin Oncol 2004;22:919–926.
14. McBride CM, Clipp E, Peterson BL, et al. Psychological impact of diagnosis and risk reduction among cancer survivors. Psycho-Oncology 2000;9:418–427.
15. Sundin EC, Horowitz MJ. Horowitz's impact of event scale evaluation of 20 years of use. Psychosom Med 2003;65:870–876.
16. Risberg T, Sorbye SW, Norum J, et al. Diagnostic delay causes more psychological distress in female than in male cancer patients. Anticancer Res 1996;16:995–999.
17. Graca PM, Figueiredo AP, Fincham FD. Anxiety, depression, traumatic stress and quality of life in colorectal cancer after different treatments: a study with Portuguese patients and their partners. Eur J Oncol Nurs 2012;16:227–232.
18. Ehlers A, Clark DM. A cognitive model of posttraumatic stress disorder. Behav Res Ther 2000;38:319–345.
19. Black EK, White CA. Fear of recurrence, sense of coherence and posttraumatic stress disorder in haematological cancer survivors. Psycho-Oncology 2005;14:510–515.
20. Custers JA, Gielissen MF, Janssen SH, et al. Fear of cancer recurrence in colorectal cancer survivors. Support Care Cancer 2015[epub ahead of print]. DOI:10.1007/s00520-015-2808-4.
21. Marventano S, Forjaz M, Grosso G, et al. Health related quality of life in colorectal cancer patients: state of the art. BMC Surg 2013;13:S15.
22. Jacobsen PB, Widows MR, Hann DM, et al. Posttraumatic stress disorder symptoms after bone marrow transplantation for breast cancer. Psychosom Med 1998;60:366–371.
23. Shelby RA, Golden-Kreutz DM, Andersen BL. PTSD diagnoses, subsyndromal symptoms, and comorbidities contribute to impairments for breast cancer survivors. J Trauma Stress 2008;21:165–172.
24. Kangas M, Henry JL, Bryant RA. Posttraumatic stress disorder following cancer. A conceptual and empirical review. Clin Psychol Rev 2002;22:499–524.
25. Miles A, McClements PL, Steele RJ, et al. The psychological impact of a colorectal cancer diagnosis following a negative fecal occult blood test result. Cancer Epidemiol Biomarkers Prev 2015;24:1032–1038. DOI:10.1158/1055-9965.EPI-15-0004.
26. National Statistics, Scotland. Scottish Index of Multiple Deprivation [internet]. Edinburgh: The Scottish Government; 2012 [cited 2014 Oct 9]. (Available from: http://simdscotlandgovuk/publication-2012.)
27. Weiss DS, Marmar CR. In The Impact of Events Scale – Revised. Assessing psychological trauma and PTSD, Wilson JP, Keane TM (eds.), The Guilford Press: New York, 1997;399–411.
28. Gurevich M, Devins GM, Rodin GM. Stress response syndromes and cancer: conceptual and assessment issues. Psychosomatics 2002;43:259–281.
29. National Centre for PTSD. Impact of Event Scale - Revised (IES-R) [internet]. Washington D.C.: U.S. Department of Veterans Affairs [cited 2015 Nov 10]. (Available from: http://www.ptsd.va.gov/professional/assessment/adult-sr/ies-r.asp.)
30. Ward WL, Hahn EA, Mo F, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res 1999;8:181–195.
31. Rabin C, Leventhal H, Goodin S. Conceptualization of disease timeline predicts posttreatment distress in breast cancer patients. Health Psychol 2004;23:407–412.
32. Muthén LK, Muthén BO. Mplus User's Guide (6th ed.), Muthén & Muthén: Los Angeles, CA, 2010.
33. Pearman T, Yanez B, Peipert J, et al. Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapy. Cancer 2014;120:2902–2909.
34. Koch L, Jansen L, Brenner H, et al. Fear of recurrence and disease progression in long-term (>/= 5 years) cancer survivors--a systematic review of quantitative studies. Psycho-Oncology 2013;22:1–11.
35. Geiser C. Data Analysis with MPlus, The Guildford Press: New York, 2013.
36. Fritz MS, MacKinnon DP. Required sample size to detect the mediated effect. Psychol Sci 2007;18:233–239.
37. Norris FH. Epidemiology of trauma: frequency and impact of different potentially traumatic events on different demographic groups. J Consult Clin Psychol 1992;60:409–418.
38. Lee-Jones C, Humphris G, Dixon R, et al. Fear of cancer recurrence – a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psycho-Oncology 1997;6:95–105.
39. Pita-Fernandez S, Pertega-Diaz S, Lopez-Calvino B, et al. Diagnostic and treatment delay, quality of life and satisfaction with care in colorectal cancer patients: a study protocol. Health Qual Life Outcomes 2013;11:117. DOI:10.1186/1477-7525-11-117.
40. Smith SG, Turner B, Pati J, et al. Psychological impairment in patients urgently referred for prostate and bladder cancer investigations: the role of trait emotional intelligence and perceived social support. Support Care Cancer 2012;20:699–704. DOI:10.1007/s00520-011-1129-5.
41. von Wagner C, Baio G, Raine R, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol 2011;40:712–718. DOI:10.1093/ije/dyr008.
42. Lutgendorf SK, Andersen BL. Biobehavioral approaches to cancer progression and survival: mechanisms and interventions. Am Psychol 2015;70:186–197. DOI:10.1037/a0035730.